Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer, finds study

For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal therapy alone, according to a study in the April issue of the Journal of Urology.

Leave A Comment

Your email address will not be published. Required fields are marked *